Cytomx Therapeutics shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Cytomx Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cytomx Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytomx Therapeutics by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.0k | 1.3k | 0.80 |
| 2022-06-30 | $27k | 15k | 1.78 |
| 2022-03-31 | $40k | 15k | 2.63 |
| 2020-12-31 | $54k | 8.3k | 6.51 |
| 2020-06-30 | $8.0k | 963 | 8.31 |
| 2020-03-31 | $380k | 50k | 7.66 |
| 2019-12-31 | $412k | 50k | 8.31 |
| 2019-09-30 | $377k | 51k | 7.36 |
| 2019-06-30 | $574k | 51k | 11.21 |
| 2019-03-31 | $550k | 51k | 10.74 |
| 2018-12-31 | $591k | 39k | 15.08 |
| 2018-09-30 | $725k | 39k | 18.49 |